137 related articles for article (PubMed ID: 19474743)
1. Management of gastroesophageal reflux disease in primary care settings in Spain: SYMPATHY I study.
Ferrús JA; Zapardiel J; Sobreviela E;
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1269-78. PubMed ID: 19474743
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240
[TBL] [Abstract][Full Text] [Related]
3. Management of reflux disease in clinical praxis in hungary.
Hritz I; Prónai L; Szalay F; Tulassay Z
Z Gastroenterol; 2005 Jun; 43(6):575-80. PubMed ID: 15986286
[TBL] [Abstract][Full Text] [Related]
4. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
6. Results of the ALEGRIA study in Luxembourg. An epidemiological, observational study to describe symptom impact and control in patients with GERD and an evaluation of the GERD Impact Scale.
Fritz R; Goodman N; Duquenne V; Taeter C
Bull Soc Sci Med Grand Duche Luxemb; 2009; (2):141-52. PubMed ID: 19999624
[TBL] [Abstract][Full Text] [Related]
7. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy.
Miyamoto M; Haruma K; Takeuchi K; Kuwabara M
J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348
[TBL] [Abstract][Full Text] [Related]
8. Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study.
Jones R; Armstrong D; Malfertheiner P; Ducrotté P
Curr Med Res Opin; 2006 Apr; 22(4):657-62. PubMed ID: 16684426
[TBL] [Abstract][Full Text] [Related]
9. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
Johnson DA; Levy BH
Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological management of gastroesophageal reflux disease.
Lowe RC; Wolfe MM
Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
[TBL] [Abstract][Full Text] [Related]
11. Frequency scale symptoms for gastroesophageal reflux disease (Frequency Scale for Symptoms of GERD) predicts need for addition of prokinetics to proton pump inhibitor therapy.
Nandurkar S
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1165-7. PubMed ID: 18699977
[No Abstract] [Full Text] [Related]
12. Structured diagnostic and treatment approach versus the usual primary care approach in patients with gastroesophageal reflux disease: a cluster-randomized multicenter study.
Bergquist H; Agréus L; Tillander L; Johnsson F; Sörngård H; Sjöstedt S; Hellström PM
J Clin Gastroenterol; 2013 Aug; 47(7):e65-73. PubMed ID: 23426452
[TBL] [Abstract][Full Text] [Related]
13. Conservative management of GERD: a case study.
Levy RA; Stamm L; Meiner SE
Medsurg Nurs; 2002 Aug; 11(4):169-75, 182; quiz 176. PubMed ID: 12219428
[TBL] [Abstract][Full Text] [Related]
14. [Study of the clinical profile and management of patients with gastroesophageal reflux disease in primary care in Spain].
Tafalla M; Nuevo J; Zapardiel J; Gisbert JP
Gastroenterol Hepatol; 2010; 33(7):490-7. PubMed ID: 20624662
[TBL] [Abstract][Full Text] [Related]
15. A primary care approach to pediatric gastroesophageal reflux.
Sunku B; Marino RV; Sockolow R
J Am Osteopath Assoc; 2000 Dec; 100(12 Suppl Pt 2):S11-5. PubMed ID: 11213657
[TBL] [Abstract][Full Text] [Related]
16. GORD.
Miller G; Charles J
Aust Fam Physician; 2009 Dec; 38(12):955. PubMed ID: 20369145
[TBL] [Abstract][Full Text] [Related]
17. [GerdQ: tool for the diagnosis and management of gastroesophageal reflux disease in primary care].
Della Casa D; Missale G; Cestari R
Recenti Prog Med; 2010 Mar; 101(3):115-7. PubMed ID: 20461953
[TBL] [Abstract][Full Text] [Related]
18. An electronic medical record-based intervention to improve quality of care for gastro-esophageal reflux disease (GERD) and atypical presentations of GERD.
Player MS; Gill JM; Mainous AG; Everett CJ; Koopman RJ; Diamond JJ; Lieberman MI; Chen YX
Qual Prim Care; 2010; 18(4):223-9. PubMed ID: 20836938
[TBL] [Abstract][Full Text] [Related]
19. New algorithm for the treatment of gastro-oesophageal reflux disease.
Tytgat GN; McColl K; Tack J; Holtmann G; Hunt RH; Malfertheiner P; Hungin AP; Batchelor HK
Aliment Pharmacol Ther; 2008 Feb; 27(3):249-56. PubMed ID: 17973975
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological study on the incidence of gastroesophageal reflux disease symptoms in patients in acute treatment with NSAIDs.
Martín-de-Argila C; Martínez-Jiménez P
Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):27-33. PubMed ID: 23265146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
